The Size of the North America Nucleic Acid Isolation and Purification Market is valued at USD 1.34 billion in 2023 and expected to grow at a CAGR of 8.96%, to reach USD 2.06 billion by 2028 during the forecast period 2023 to 2028.
The rising adoption of sequencing platforms in clinical diagnostics, expansion in genomics and enzymology-based research, technological advancements, and the development of automation and increasing investments in R&D relevant to molecular biology and precision medicine contribute to North America Nucleic Acid Isolation and Purification market growth.
The nucleic acid isolation and purification market's high scope of development, improving regulating and reimbursement settings, and diagnostics and personalized treatment are all extending profitable options in the market's expansion. Robotic liquid handling in automated DNA extraction systems, for instance, has enhanced the process flow. All of the tasks required in various processes, such as DNA extraction from samples, serial dilution, and selecting the desired gene of interest, have been streamlined due to this automation.
In addition, the production of genetically modified crops has been revolutionized due to rapid technological advancements in the agriculture industry. Drought, herbicide, and insect and pest resistance are all qualities developed by genetic engineering in genetically engineered crops. As a result, the number of nucleic acid extraction processes is rapidly increasing. It also improves nucleic acid purification.
The most common nucleic acid separation and purification technologies are column-based, reagent-based, magnetic bead-based, and others. Hospitals, pharmaceutical firms, academic research institutions, diagnostic centers, biotechnology companies, and food testing and laboratories all employ them. The presence of established companies in the region and their attempts to develop technologically advanced quick purification and isolation technologies is a significant contributor to market growth. Several RNA species contain a largely unexplored class of biomolecules that play a critical role in disease progression.
This has improved the RNA pipeline, allowing nucleic acid isolation and drug manufacture purification processes to be used. The purification of nucleic acids has been dramatically enhanced due to the increased usage of high-performance and computerized isolation technologies.
One of the reasons expected to stifle the expansion of the nucleic acid isolation and purification industry is the high costs of automated instruments. As a result, purification techniques and mechanical nucleic acid isolation have low market penetration, a significant hurdle to industry expansion. Furthermore, the high cost of the tools used in these operations hinders the North American market's growth.
This research report on the North America Nucleic Acid Isolation and Purification Market has been segmented and sub-segmented into the following categories
By End User:
Geographically, the North American region will be boosted by enormous R&D spending in biotechnology and pharmaceutical businesses, technological improvements, and government support. Because biotechnology and pharmaceutical businesses invest heavily in research and development, North America dominates the nucleic acid isolation and purification market.
Furthermore, rising economic growth, substantial life sciences research, a growing patient population, supportive government initiatives, and several innovative biotech companies in the region contribute to the market's growth in the area. The presence of well-established healthcare infrastructure is driving the entire regional market's transition to a great extent.
KEY MARKET PLAYERS:
Promising Companies dominating the North America Nucleic acid isolation and purification market Profiled in the Report are Qiagen, Bio-Rad Laboratories Inc, Illumina Inc, Agilent Technologies Inc, Thermo Fischer Scientific Inc, F. Hoffmann-La Roche AG, Sigma-Aldrich Co. LLC, General Electric Company, Danaher Corporation, Promega Corporation, Life Technologies, Roche Applied Sciences, Takara Bio, Inc., etc.,
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com